Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Pantoprazole Regimens for Peptic Ulcer Bleeding
NCT00731601Phase 4
Key facts
- Status
- Completed
- Start
- May 2008
- Primary completion
- Mar 2009
- Countries
- 1
- Sponsor
- Lotung Poh-Ai Hospital
- Modality
- Small Molecules
- Drugs
- pantoprazole
- Conditions
- Peptic ulcer hemorrhage (PUB)
01
Overview
Phase 4, randomised trial of pantoprazole in Peptic ulcer hemorrhage (PUB) (2 arms), sponsored by Lotung Poh-Ai Hospital. Primary endpoint: Recurrent bleeding before discharge and within 14 days. Started May 2008; status: completed.
02
Design
2 arms- Study design
- Randomized
Intermittent
Pantoprazole 40mg/q6h IV infusion for three days
Continuous
Pantoprazole 8mg/h IV infusion for three days
03
Endpoints
Primary
Recurrent bleeding before discharge and within 14 days
Secondary
Volume of blood transfused
Number of surgeries performed
Mortality rates
Beyond the preview
Go deeper on NCT00731601.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00731601.